@inproceedings{inproceedings, title  = {{SAFETY OF CYTOTOXIC CHEMOTHERAPY FOLLOWING RADIUM-223 CHLORIDE (RA-223) THERAPY IN THE PHASE 3 ALSYMPCA STUDY IN PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER (CRPC) WITH BONE METASTASES}},

 url = {{}},

 year = {{2012}},

 month = {{9}},

 author = {{Sartor O and Coleman RE and Nilsson S and Vogelzang N and Cross A and O'Bryan-Tear G and Staudacher K and Garcia-Vargas JE and Zou J and Parker C}},

 volume = {{23}},

 journal = {{ANNALS OF ONCOLOGY}},

 pages = {{308-309}},

 note = {{Accessed on 2025/10/10}}}